Supplements · Metabolic & Cardiometabolic

fatty fish decreases blood triglycerides

In plain terms: Does fish lower triglycerides?

Strong support Supplements 🔬 Includes disconfirming

RefutedContestedStrong support

consensus score 0.74

Yes - lowering triglycerides is one of the best-established effects of marine omega-3s, with a clear dose-response and a known mechanism. Eating fatty fish like salmon helps, but the big drops usually take supplement-level doses well above a normal fish meal.

📅 Last reviewed: 2026-07-15 ⓘ

Evidence ladder

How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."

Top evidence so far: All trials, pooled (Meta-analysis)

MechanismIn-vitroAnimalObservationalRCTMeta-analysis

How the studies fall

12 support 0 contradict 3 tested null 3 mixed · 18 sources, 12 independent groups

What the evidence shows

That marine omega-3s lower triglycerides is well established — many randomized trials show clear, dose-dependent reductions (larger at higher doses), with a solid mechanism (they cut production of the triglyceride carrier apoC-III). Feeding studies using actual fatty fish (like salmon) also lower triglycerides and raise HDL.

Cochrane agrees with us see how our grade compares ▾

Cochrane review 2020 · moderate to low Agrees with our grade

SCOPE: evidence is mainly from SUPPLEMENT trials, whereas our claim is about fatty fish as a food.

“Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease (CD003177.pub5). 'Moderate- and low-certainty evidence suggests that increasing LCn3 slightly reduces risk of coronary heart disease mortality and events, and reduces serum triglycerides (evidence mainly from supplement trials).'”

Why we agree: we reached the same direction independently, from our own appraisal of 18 sources. Two methods landing in the same place is a stronger signal than either alone.

What is Cochrane, and why trust it?

Cochrane produces systematic reviews: instead of running a new study, they gather every trial ever done on a question, judge how well each was run, and pool the results. They take no commercial or industry funding, which is why the medical community treats their reviews as a gold standard — and why we check our own verdicts against theirs.

About Cochrane ↗ · Get involved / support ↗

Read the Cochrane review ↗

The evidence (18)

Source	Grade	Stance	Quality	Finding
Wang Y et al. 2024 · Front Immunol	meta-analysis	supports	moderate	Meta 18 RCTs: omega-3 significantly decreased triglycerides (SMD -0.47) [supplement].
Curry SA et al 2026 · study_type: animal	animal	mixed	low	Heat-stressed wether lambs given fish oil partially recovered heat-stress-induced deficits in circulating triglycerides and HDL-cholesterol, but not free fatty acids; a separate omega-3 Ca-salt fully resolved other lipid-flux deficits.
Al-Muzafar HM et al 2026 · study_type: animal	animal	supports	moderate	Rats on high-cholesterol diet given fish oil showed reduced TG, LDL, TC, and inflammatory/endothelial markers vs HCD-only controls (n=80 rats, 5 groups, 8 weeks).
Rajaram S et al. 2009 · Am J Clin Nutr	RCT	supports	moderate	Crossover RCT (25): salmon diet decreased serum TG and raised HDL vs control/walnut diets [fish-intake].
Samankan S et al. 2025 · Clin Transplant	meta-analysis	mixed	moderate	Meta 16 RCTs (transplant patients): omega-3 TG effects inconsistent and largely non-significant [supplement].
Sahebkar A et al. 2018 · J Clin Lipidol	meta-analysis	supports	moderate	Meta (2,062): omega-3 significantly reduces apoC-III, a key regulator of triglyceride metabolism (mechanism) [supplement].
Mohammady M et al. 2024 · Cochrane Database Syst Rev	meta-analysis	tested-null	high	Cochrane 15 RCTs: omega-3 no significant TG difference in intermittent-claudication patients [supplement].
Jurek JM et al 2026 · study_type: animal	meta-analysis	supports	moderate	Systematic review of 7 RCTs (2020-2026) in MASLD adults found fish oil/omega-3 supplementation produced modest improvements in lipid profiles and hepatic markers; freshwater fish also beneficial.
Gao H et al. 2020 · Nutr Metab (Lond)	meta-analysis	supports	moderate	Meta 12 RCTs (T2D): fish oil lowered TG (effect -0.40) and raised HDL [supplement].
Utri-Khodadady Z et al. 2024 · Nutrients	RCT	tested-null	low	RCT (38): farmed salmon 200 g/wk did not significantly change TG overall; increased in high-WHtR subgroup [fish-intake].
Basirat V et al. 2025 · Lipids Health Dis	meta-analysis	supports	high	Meta 21 RCTs: marine omega-3 substantial dose-dependent TG reduction (up to -57 mg/dL at >2000 mg/d) [supplement].
Lindqvist H et al. 2009 · Lipids	RCT	mixed	low	Crossover RCT (35): herring raised HDL; TG fell on both herring and reference diets (no between-diet difference) [fish-intake].
Gallo Ruelas M et al. 2025 · Clin Nutr ESPEN	meta-analysis	supports	moderate	Meta 9 RCTs: seal-oil marine omega-3 modestly lowered TG (-0.19 mmol/L); low certainty [supplement].
Dawczynski C et al. 2025 · Nutrients	RCT	supports	moderate	RCT (65): menu plan + fish oil reduced TG 28% vs 14% with diet alone over 20 weeks [mixed].
Aadland EK et al. 2015 · Am J Clin Nutr	RCT	supports	low	Crossover RCT (20): lean-seafood intake reduced fasting and postprandial TG vs non-seafood protein [fish-intake].
Liu SH et al 2025 · J Food Drug Anal	animal	tested-null	low	On the claim's outcome the paper is null, not supportive: 'Triglyceride (TG) levels were significantly lower in both the HF and HFF groups compared to the N group, with no difference between the HF and HFF groups' - Table 4, HF 59.6 +/- 13.5 vs HF+5% fish oil 42.8 +/- 7.5 mg/dL, both carrying significance letter b (n = 8/group, 21 wk). Total cholesterol WAS significantly reduced (324.5 -> 130.7 mg/dL) but TC is not this claim's object. Quality low: the abstract and discussion both assert a significant plasma-TG reduction the paper's own Table 4 does not show; there is no normal-diet + fish-oil arm (authors list this as a limitation); the HF control was not hypertriglyceridemic, so there was no elevated TG to correct; and HDL-C fell further on fish oil (61.8 -> 44.6 mg/dL). tested-null rather than contradicts because n = 8/group with a -28% point estimate is not the well-powered null CONVENTIONS requires for a disconfirming vote.
Li J et al 2026 · study_type: animal	animal	supports	low	Mice on high-sucrose high-fat diet given enzymatically modified grass-carp fish oil (MFO) showed alleviated obesity, hepatic steatosis, and dyslipidemia vs controls. No blood-TG % figure given; modified/enriched oil, not standard fish oil.
Zhuang P et al 2026 · study_type: RCT	RCT	supports	high	415 T2D patients, 14-month double-blind RCT of high-dose (3g/d) vs low-dose (1.5g/d) marine n-3 vs placebo; high-dose significantly reduced remnant cholesterol, LDL-TG, HDL-4-TG, HDL-3-TG subclasses, but did not significantly reduce carotid

Disagree, or know a study we missed?

We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.

📚 Suggest a study ⚑ Flag / request reclassification

Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).

Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.